Estimating the association between SF-12 responses and EQ-5D utility values by response mapping

被引:174
|
作者
Gray, AM [1 ]
Rivero-Arias, O [1 ]
Clarke, PM [1 ]
机构
[1] Univ Oxford, Hlth Econ Res Ctr, Dept Publ Hlth, Oxford OX3 7LF, England
关键词
health status; SF-12; SF-36; EQ-5D; utility values;
D O I
10.1177/0272989X05284108
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Reliably mapping from generic or disease-specific health status measures into health state utilities would assist health economists. Existing studies mainly use ordinary least squares (OLS) regression equations to predict utility values for particular health states. The authors examine an alternative approach to map between 2 generic health status instruments, the SF-12 and the EQ-5D. Methods. Multinomial logit regression is used to estimate the probability that a respondent will select a particular level of response to questions in the EQ-5D, using individual question responses and summary scores from the SF-12 as predictors. Monte Carlo simulation methods are used to generate predicted EQ-5D responses, and utility scores (tariffs) are then attached. Results are compared with an alternative approach based on direct mapping to utility scores using OLS. Data. The authors estimate equations using 12,967 adult survey responses from the 2000 US Medical Expenditure Panel Survey. They report mean squared error (MSE) and mean absolute error (MAE) of their predicted utilities within this sample, and out-of-sample using 13,304 adults from the 1996 Health Survey for England. Results. The authors obtain an in-sample and out-of-sample MSE of 0.03, compared with 0.02 for the OLS approach. Their MAE of 0.11 is similar to OLS results. The authors' method predicts group mean utility scores and differentiates between groups with or without known existing illness. Conclusions. The authors' approach has higher MSE than the direct OLS approach but gives more descriptive data on domains of health effects. Further out-of-sample prediction work will help test the validity of these methods.
引用
收藏
页码:18 / 29
页数:12
相关论文
共 50 条
  • [1] ESTIMATING THE ASSOCIATION BETWEEN SF-12 RESPONSES TO EQ-5D UTILITY VALUES USING A RESPONSE MAPPING AND A PARAMETER UNCERTAINTY APPROACH
    Rivero-Arias, O.
    Gray, A.
    Ramos-Goni, J. M.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A248 - A248
  • [2] Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
    Belinda J Gabbe
    Emma McDermott
    Pam M Simpson
    Sarah Derrett
    Shanthi Ameratunga
    Suzanne Polinder
    Ronan A Lyons
    Frederick P Rivara
    James E Harrison
    [J]. Population Health Metrics, 13
  • [3] VALIDITY OF EQ-5D AND SF-12 AMONG MALAYSIAN
    Shafie, A. A.
    Hassali, M. A.
    Liau, S. Y.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A542 - A542
  • [4] Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
    Gabbe, Belinda J.
    McDermott, Emma
    Simpson, Pam M.
    Derrett, Sarah
    Ameratunga, Shanthi
    Polinder, Suzanne
    Lyons, Ronan A.
    Rivara, Frederick P.
    Harrison, James E.
    [J]. POPULATION HEALTH METRICS, 2015, 13
  • [5] Mapping the SF-12 to the EuroQol EQ-5D index in a national US sample
    Franks, P
    Lubetkin, EI
    Gold, MR
    Tancredi, DJ
    Jia, HM
    [J]. MEDICAL DECISION MAKING, 2004, 24 (03) : 247 - 254
  • [6] EQ-5D Versus SF-12 in Coronary Patients: Are They Interchangeable?
    De Smedt, Delphine
    Clays, Els
    Annemans, Lieven
    De Bacquer, Dirk
    [J]. VALUE IN HEALTH, 2014, 17 (01) : 84 - 89
  • [7] Comparison of the EQ-5D and SF-12 in an adult US sample
    J. A Johnson
    S. J Coons
    [J]. Quality of Life Research, 1998, 7 : 155 - 166
  • [8] Comparison of the EQ-5D and SF-12 in an adult US sample
    Johnson, JA
    Coons, SJ
    [J]. QUALITY OF LIFE RESEARCH, 1998, 7 (02) : 155 - 166
  • [9] Converting the SF-12 into the EQ-5D An Empirical Comparison of Methodologies
    Chuang, Ling-Hsiang
    Kind, Paul
    [J]. PHARMACOECONOMICS, 2009, 27 (06) : 491 - 505
  • [10] The validity of estimating EQ-5D and SF-6D utility values from the HAP
    Harrison, Mark J.
    Lunt, Mark
    Bansback, Nick
    Verstapen, Suzanne
    Watson, Kath
    Symmons, Deborah
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S204 - S204